Oura IPO Oversubscribed Fourfold with $2.2 Billion Target, Bloomberg Reports

Health technology company Oura Inc. is seeing strong investor demand for its initial public offering, with orders totaling approximately four times the number of shares being offered, according to a report from Bloomberg News citing people familiar with the matter.

The wearable tech firm's IPO is targeting a total capital raise of up to $2.2 billion, a significant milestone for the consumer health market. The strong demand indicates a potentially robust market debut for the company, with banks managing the sale planning to close the order book on Monday afternoon, one source told Bloomberg.

Offering Details

According to filings with the U.S. Securities and Exchange Commission (SEC), Oura and its existing shareholders are offering a combined 50 million shares. The shares are being marketed within a price range of $40 to $44 each.

The offering is comprised of two parts:

Ad

• 13.5 million new shares are being sold by the company itself to raise fresh capital.
• 36.5 million shares are being offered by existing shareholders, including early investors like Forerunner Ventures and Lifeline Ventures.

Market Context

The high level of oversubscription is a key indicator of investor sentiment and confidence in Oura's business model and growth prospects ahead of its public listing. A successful IPO would provide a major liquidity event for its early backers and fuel the company's expansion plans.

A consortium of high-profile investment banks is leading the offering. The SEC filings list Goldman Sachs Group Inc., Morgan Stanley, JPMorgan Chase & Co., Allen & Co., and Jefferies Financial Group Inc. as the lead underwriters for the deal.